Intriguingly, EXO1 deficiency does not lead to TMZ resistance in TK6 cells and instead somewhat hyper-sensitizes to TMZ, which is in disagreement with the result of CRISPR-based genome-wide screen carried out in TMZ-treated MGMT-negative glioblastomas (71). Here, EXO1 is linked to glioblastoma.